{"id":"https://openalex.org/W2000303505","doi":"https://doi.org/10.4088/jcp.v66n1110","title":"Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine","display_name":"Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine","alternate_titles":[],"publication_year":2005,"publication_date":"2005-11-15","ids":{"openalex":"https://openalex.org/W2000303505","doi":"https://doi.org/10.4088/jcp.v66n1110","mag":"2000303505","pmid":"https://pubmed.ncbi.nlm.nih.gov/16420078"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v66n1110","doi":"https://doi.org/10.4088/jcp.v66n1110","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v66n1110","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000303505"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113585390","display_name":"James Craig Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Craig Nelson","raw_affiliation_strings":["Department of Psychiatry, University of California-San Francisco, 401 Parnassus Avenue, PO Box 0984-F, San Francisco, CA 94143, USA. craign@lppi.ucsf.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of California-San Francisco, 401 Parnassus Avenue, PO Box 0984-F, San Francisco, CA 94143, USA. craign@lppi.ucsf.edu","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073560397","display_name":"Laura Portera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura Portera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111561486","display_name":"Andrew C. Leon","orcid":"https://orcid.org/0009-0008-0191-4601","observed_orcids":["https://orcid.org/0009-0008-0191-4601"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew C. Leon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.8763,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.90380117,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"66","issue":"11","first_page":"1409","last_page":"1414"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10214","display_name":"Psychotherapy Techniques and Applications","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/residual-depressive-symptoms","display_name":"residual depressive symptoms","score":0.9789999723434448},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.921999990940094},{"id":"https://openalex.org/keywords/reboxetine","display_name":"reboxetine","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.7749999761581421},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9629999995231628},{"id":"https://openalex.org/keywords/norepinephrine-reuptake-inhibitors","display_name":"norepinephrine reuptake inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.7020000219345093},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.5199999809265137},{"id":"https://openalex.org/keywords/low-libido","display_name":"low libido","score":0.7149999737739563},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.6309999823570251},{"id":"https://openalex.org/keywords/sleep-disturbance","display_name":"sleep disorders","score":0.9079999923706055},{"id":"https://openalex.org/keywords/antidepressant-side-effects","display_name":"antidepressant side effects","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.8732910752296448},{"id":"https://openalex.org/C2780467756","wikidata":"https://www.wikidata.org/wiki/Q418970","display_name":"Reboxetine","level":5,"score":0.7453398704528809},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.6926565766334534},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.57603919506073},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.548895001411438},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5267761945724487},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5186690092086792},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5101078152656555},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.5057163238525391},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.48853954672813416},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4767951965332031},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3567442297935486},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.2895188331604004},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.26679283380508423},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.18978020548820496},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077593","descriptor_name":"Reboxetine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007989","descriptor_name":"Libido","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012893","descriptor_name":"Sleep Wake Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012893","descriptor_name":"Sleep Wake Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020018","descriptor_name":"Sexual Dysfunctions, Psychological","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D020018","descriptor_name":"Sexual Dysfunctions, Psychological","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v66n1110","doi":"https://doi.org/10.4088/jcp.v66n1110","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v66n1110","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:16420078","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16420078","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1983861814","https://openalex.org/W2056454671","https://openalex.org/W2062899422","https://openalex.org/W1969966668","https://openalex.org/W2239519232","https://openalex.org/W2057989510","https://openalex.org/W2125412819","https://openalex.org/W1967365900","https://openalex.org/W2367473444","https://openalex.org/W2071936930"],"abstract_inverted_index":{"BACKGROUND:":[0],"Residual":[1],"symptoms":[2,23,35,103,144,227],"are":[3],"common":[4],"and":[5,30,66,74,99,112,130,139,156,199,210,239],"have":[6,20],"a":[7,251,257],"variety":[8],"of":[9,32,101,152,261],"consequences":[10],"in":[11,36,106,167,196,225,228,254],"depressed":[12,157,229],"patients":[13,108,127,136,230],"who":[14,76,109,231],"respond":[15],"to":[16,174,233],"treatment,":[17],"but":[18],"seldom":[19],"specific":[21],"residual":[22,33,102,160,206,226],"been":[24],"assessed.":[25],"We":[26],"examined":[27],"the":[28,40,48,89,107,120,236,240,244,247],"frequency":[29,98],"severity":[31,100],"depressive":[34],"2":[37],"studies":[38,63,71],"comparing":[39,64],"selective":[41],"serotonin":[42],"reuptake":[43,50],"inhibitor":[44,51],"(SSRI)":[45],"fluoxetine":[46,65,195,238,248],"with":[47,88,194,235,243],"norepinephrine":[49],"(NRI)":[52],"reboxetine.":[53],"METHOD:":[54],"Data":[55],"from":[56],"two":[57],"8-week,":[58],"previously":[59],"published,":[60],"double-blind,":[61],"random-assignment":[62],"reboxetine":[67],"were":[68,86,104,148],"obtained.":[69],"Both":[70],"included":[72],"men":[73],"women":[75],"met":[77],"DSM-III-R":[78],"criteria":[79],"for":[80,94,176,205],"unipolar":[81],"nonpsychotic":[82],"major":[83],"depression.":[84],"Symptoms":[85],"assessed":[87],"21-item":[90],"Hamilton":[91],"Rating":[92],"Scale":[93],"Depression":[95],"(HAM-D).":[96],"The":[97,141],"determined":[105],"completed":[110,128,137],"treatment":[111,129,138,147,165,234],"responded":[113,232],"(had":[114],"at":[115],"least":[116],"50%":[117],"improvement":[118],"on":[119],"HAM-D).":[121],"RESULTS:":[122],"In":[123,132],"study":[124,133,197,200,221],"1,":[125],"117":[126],"responded.":[131,140],"2,":[134],"113":[135],"most":[142],"frequent":[143],"present":[145],"after":[146],"psychic":[149],"anxiety,":[150,155,207],"lack":[151],"interest,":[153,256],"somatic":[154],"mood.":[158],"No":[159],"symptom":[161,178],"differed":[162],"significantly":[163,192],"between":[164,184,216],"groups":[166,186],"both":[168],"samples.":[169],"Ordinal":[170],"logistic":[171],"regression,":[172],"used":[173],"control":[175],"baseline":[177],"severity,":[179],"revealed":[180],"no":[181,223],"other":[182],"differences":[183,224],"drug":[185,217],"except":[187],"that":[188,246,262],"decreased":[189],"libido":[190],"was":[191],"greater":[193,252],"1":[198],"2.":[201],"Three":[202],"composite":[203],"scores":[204],"sleep":[208],"disturbance,":[209],"reduced":[211],"drive":[212],"did":[213],"not":[214],"differ":[215],"groups.":[218],"CONCLUSION:":[219],"This":[220],"found":[222],"SSRI":[237],"NRI":[241],"reboxetine,":[242],"exception":[245],"group":[249],"had":[250],"decrease":[253],"sexual":[255],"likely":[258],"side":[259],"effect":[260],"drug.":[263]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000303505","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
